ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
2017 · Vaccine · 162 citations
https://doi.org/10.1016/j.vaccine.2017.05.032
N
Naif Khalaf Alharbi
Cairo University(EG)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
102
Papers
2.1K
Citations
21
h-index
41
i10-index
Naif Khalaf Alharbi is an academic researcher from Cairo University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Animal Virus Infections Studies. The author has an h-index of 21, co-authored 87 publications.
ORCID: 0000-0002-6049-3383Papers by this author
worksEfficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial
2022 · Clinical Microbiology and Infection · 100 citations
https://doi.org/10.1016/j.cmi.2021.12.026
Challenge infection model for MERS-CoV based on naturally infected camels
2020 · Virology Journal · 17 citations
https://doi.org/10.1186/s12985-020-01347-5
Antimicrobial resistance: A round table discussion on the “One Health” concept from the Gulf Cooperation Council Countries. Part One: A focus on Leadership
2018 · Journal of Infection and Public Health · 16 citations
https://doi.org/10.1016/j.jiph.2018.05.007
Antimicrobial resistance: A round table discussion on the “One Health” concept from the Gulf Cooperation Council Countries. Part Two: A focus on Human Health
2018 · Journal of Infection and Public Health · 15 citations
https://doi.org/10.1016/j.jiph.2018.05.008
Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi Arabia
2022 · Journal of Infection and Public Health · 13 citations
https://doi.org/10.1016/j.jiph.2022.04.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat